How predictive are photosensitive epilepsy models as proof of principle trials for epilepsy?
- 1 June 2014
- journal article
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 23 (6) , 490-493
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Effects of Marketed Antiepileptic Drugs and Placebo in the Human Photosensitivity Screening ProtocolNeurotherapeutics, 2014
- Efficacy of the histamine 3 receptor (H3R) antagonist pitolisant (formerly known as tiprolisant; BF2.649) in epilepsy: Dose-dependent effects in the human photosensitivity modelEpilepsy & Behavior, 2013
- Evaluation of brivaracetam, a novel SV2A ligand, in the photosensitivity modelNeurology, 2007
- Evaluation of carisbamate, a novel antiepileptic drug, in photosensitive patients: An exploratory, placebo-controlled studyEpilepsy Research, 2007
- Proof of principle studiesEpilepsy Research, 2006
- Photosensitive epilepsy: a model to study the effects of antiepileptic drugs. Evaluation of the piracetam analogue, levetiracetamEpilepsy Research, 1996
- Preliminary Assessment of the Efficacy of Org 6370 in Photosensitive Epileptic Patients: Paradoxical Enhancement of Photosensitivity and Provocation of Myoclonic SeizuresEpilepsia, 1992
- Single-dose efficacy evaluation of loreclezole in patients with photosensitive epilepsyEpilepsy Research, 1990
- Inhibition of photosensitive seizures in man by the β-carboline, ZK 95962, a selective benzodiazepine receptor agonistEpilepsy Research, 1990
- Photosensitivity as a model for acute antiepileptic drug studiesElectroencephalography and Clinical Neurophysiology, 1986